COMPASS Pathways to participate in upcoming Evercore, H.C. Wainwright & Berenberg investor conferences

A live audio webcast of the Evercore fireside chat and the H.C. Wainwright presentation will be available on the “Events” page of the Investors section of the COMPASS website. 

Category Press Release
Country United Kingdom

Companies Featured

COMPASS Pathways
COMPASS Pathways is a publicly listed company (NASDAQ) that is developing psilocybin for treatment-resistant depression (TRD) for which it has completed a successful Phase IIb trial. COMPASS is one of the largest psychedelic companies and has received substantial investment from atai.